Skip to content
August 13, 2022

Equity.Guru

Investment information for the new generation

NCNA.Q

NuCana PLC (NCNA.Q) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Acerlarin® (NUC-1031), which is currently being evaluated in a Phase…